134 related articles for article (PubMed ID: 38170398)
1. Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods.
Wang M; Huang K; Wong MCS; Huang J; Jin Y; Zheng ZJ
J Epidemiol Glob Health; 2024 Mar; 14(1):94-101. PubMed ID: 38170398
[TBL] [Abstract][Full Text] [Related]
2. Global incidence of oesophageal cancer by histological subtype in 2012.
Arnold M; Soerjomataram I; Ferlay J; Forman D
Gut; 2015 Mar; 64(3):381-7. PubMed ID: 25320104
[TBL] [Abstract][Full Text] [Related]
3. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
Islami F; Fedewa SA; Jemal A
Prev Med; 2019 Jun; 123():316-323. PubMed ID: 31002830
[TBL] [Abstract][Full Text] [Related]
4. Comparison of adenocarcinoma (ACA) and squamous cell carcinoma (SCC) of the uterine cervix in a sub-optimally screened cohort: a population-based epidemiologic study of 51,842 women in Brazil.
Nogueira-Rodrigues A; Ferreira CG; Bergmann A; de Aguiar SS; Thuler LC
Gynecol Oncol; 2014 Nov; 135(2):292-6. PubMed ID: 25130677
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Cervical Adenocarcinoma and Squamous Cell Carcinoma Among Women Living With Human Immunodeficiency Virus Compared With the General Population in the United States.
Rositch AF; Levinson K; Suneja G; Monterosso A; Schymura MJ; McNeel TS; Horner MJ; Engels E; Shiels MS
Clin Infect Dis; 2022 Mar; 74(5):814-820. PubMed ID: 34143885
[TBL] [Abstract][Full Text] [Related]
6. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study.
Mix JM; Van Dyne EA; Saraiya M; Hallowell BD; Thomas CC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):30-37. PubMed ID: 33082207
[TBL] [Abstract][Full Text] [Related]
7. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study.
Zhang Y; Vaccarella S; Morgan E; Li M; Etxeberria J; Chokunonga E; Manraj SS; Kamate B; Omonisi A; Bray F
Lancet Oncol; 2023 Nov; 24(11):1206-1218. PubMed ID: 37837979
[TBL] [Abstract][Full Text] [Related]
8. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
[TBL] [Abstract][Full Text] [Related]
9. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
Morgan E; Soerjomataram I; Rumgay H; Coleman HG; Thrift AP; Vignat J; Laversanne M; Ferlay J; Arnold M
Gastroenterology; 2022 Sep; 163(3):649-658.e2. PubMed ID: 35671803
[TBL] [Abstract][Full Text] [Related]
10. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.
Wang SS; Sherman ME; Hildesheim A; Lacey JV; Devesa S
Cancer; 2004 Mar; 100(5):1035-44. PubMed ID: 14983500
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
Mathew A; George PS
Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
[TBL] [Abstract][Full Text] [Related]
12. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
Lönnberg S; Hansen BT; Haldorsen T; Campbell S; Schee K; Nygård M
Int J Cancer; 2015 Oct; 137(7):1758-64. PubMed ID: 25833121
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
15. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
16. [Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].
Giorgi Rossi P; Chini F; Borgia P; Guasticchi G; Carozzi FM; Confortini M; Angeloni C; Buzzoni C; Buonaguro FM;
Epidemiol Prev; 2012; 36(2):108-19. PubMed ID: 22706361
[TBL] [Abstract][Full Text] [Related]
17. Regional variation in histopathology-specific incidence of invasive cervical cancer among Peruvian women.
Pierce Campbell CM; Curado MP; Harlow SD; Soliman AS
Int J Gynaecol Obstet; 2012 Jan; 116(1):47-51. PubMed ID: 22036058
[TBL] [Abstract][Full Text] [Related]
18. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Morgan E; Soerjomataram I; Gavin AT; Rutherford MJ; Gatenby P; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Jackson C; Kozie S; Little A; Møller B; Shack L; Tervonen H; Thursfield V; Vernon S; Walsh PM; Woods RR; Finley C; Merrett N; O'Connell DL; Reynolds JV; Bray F; Arnold M
Gut; 2021 Feb; 70(2):234-242. PubMed ID: 32554620
[TBL] [Abstract][Full Text] [Related]
19. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.
Chaturvedi AK; Kleinerman RA; Hildesheim A; Gilbert ES; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fossa SD; Joensuu H; Travis LB; Engels EA
J Clin Oncol; 2009 Feb; 27(6):967-73. PubMed ID: 19114696
[TBL] [Abstract][Full Text] [Related]
20. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
Lei J; Andrae B; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Wang J; Fang F; Dillner J; Elfström KM; Sparén P
BMJ; 2019 Apr; 365():l1207. PubMed ID: 30944091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
